Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ISRCTN |
Last refreshed on:
|
13 January 2015 |
Main ID: |
ISRCTN33488737 |
Date of registration:
|
23/01/2004 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Effectiveness of Patient Controlled Epidural Analgesia (PCEA) compared with Continuous Epidural Infusion Analgesia (CEIA) in patients undergoing elective Large Bowel Resection
|
Scientific title:
|
|
Date of first enrolment:
|
01/10/2000 |
Target sample size:
|
0 |
Recruitment status: |
Completed |
URL:
|
http://isrctn.com/ISRCTN33488737 |
Study type:
|
Interventional |
Study design:
|
Randomised controlled trial (Not Specified)
|
Phase:
|
|
|
Countries of recruitment
|
United Kingdom
| | | | | | | |
Contacts
|
Name:
|
|
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
|
|
Name:
|
Jeremy
Nightingale |
Address:
|
Anaesthetic Department
Portsmouth Hospitals NHS Trust
Queen Alaxandra Hospital
Southwick Hill Road
Cosham
PO6 3LY
Portsmouth
United Kingdom |
Telephone:
|
+44 (0)1705 286279 |
Email:
|
captainsensible@soberton.swinternet.co.uk |
Affiliation:
|
|
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: Adult patients admitted to the Queen Alexandra Hospital for elective large bowel resection will be approached.
Exclusion criteria: Patients with contra-indication to epidural analgesia, poor co-ordination and hand arthritis.
Age minimum:
Age maximum:
Gender:
Not Specified
|
Health Condition(s) or Problem(s) studied
|
Symptoms and general pathology: Pain Signs and Symptoms Pain
|
Intervention(s)
|
i. PCEA or ii. CEIA using Bupivacaine 0.125% with Fentanyl 4 µg/ml via a Graseby 9500 pump. Patients in both groups will receive a loading dose of bupivacaine 0.25% via the epidural catheter, which is then attached to the pump. For patients in the CEIA group (controls) the pump will be programmed to deliver a continuous infusion of 10 ml/hour but the patient demand button will be disabled although it will still make a 'click noise' when pressed. For those in the PCEA arm, the pump will be programmed to deliver a continual dose of 8 ml/hour and a bolus dose of 3 ml on activation of the patient demand button, with a lockout interval of 20 min.
|
Primary Outcome(s)
|
a. Pain scores: This will be recorded using the hospital standard system which has been adopted by Wessex Acute Pain Forum as part of the minimum data set. It is a simple numerical scale of 0-3. In addition a standard 10 cm Vas marked at either extreme is used. Data will be collected hourly for the first 4 hours and 4 hourly thereafter. Patient will be scored at rest and on movement. b. Patient's perception on control: In order to incorporate the notion of control we will utilise a standardised questionnaire to measure 'beliefs about controlling pain' c. Patient's overall satisfaction of their pain control: at 72 hours and on discharge (between days 7-10), patients will be asked to record their overall impression of their pain control d. Side effects: All patients will be assessed for incidence of sedation, nausea and vomiting, and respiratory depression. Pruritus and urinary retention will be noted and treated accordingly. e. Analgesia usage: Consumption of epidural drugs and requirement for rescue analgesia will be recorded for all patients
|
Secondary Outcome(s)
|
Not provided at time of registration
|
Source(s) of Monetary Support
|
NHS Executive South East (UK)
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|